AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (1.7 MB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression

Jun Wang1,2,*, Hui Xu1,*, Shuang Ge1, Chaoshuai Xue1, Hailing Li1, Xiaotong Jing1, Ke Liang3, Xiaoying Zhang1, Cuijuan Zhang1,3 ( )
Institute of Pathology and Pathophysiology, Shandong University School of Medicine, Jinan 250012, China
Department of Pathology, Qianfoshan Hospital, Jinan 250300, China
Department of Pathology, Qilu Hospital of Shandong University, Jinan 250012, China

*These authors contributed equally to this work.

Show Author Information

Abstract

Objective

The function of euchromatic histone-lysine N-methyltransferase 2 (EHMT2) has been studied in several cancers; however, little is known about its role in mantle cell lymphoma (MCL). Thus, this study aimed to characterize the significance and function of EHMT2 in MCL.

Methods

EHMT2 expression in MCL and reactive hyperplasia (RH) were investigated by immunohistochemistry. Genome-wide analysis of DNA methylation was performed on EHMT2 + MCL samples. The function of EHMT2 was determined by CCK8, flow cytometry, and western blot assays. Gene expression profile analysis was performed before and after EHMT2 knockdown to search for EHMT2-regulated genes. Co-immunoprecipitation (Co-IP) experiments were conducted to identify the proteins interacting with EHMT2.

Results

EHMT2 was expressed in 68.57% (24/35) of MCLs but not in any RHs. Genome-wide analysis of DNA methylation on EHMT2 + MCLs revealed that multiple members of the HOX, FOX, PAX, SOX, and CDX families were hypermethylated or hypomethylated in EHMT2 + MCLs. BIX01294, a EHMT2 inhibitor, inhibited MCL cell growth and stalled cells in the G1 phase. Additionally, BIX01294 downregulated the expressions of cell cycle proteins, cyclin D1, CDK4, and P21, but upregulated the expressions of apoptosis-related proteins, Bax and caspase-3. Co-IP experiments revealed that EHMT2 interacted with UHRF1, HDAC1, and HDAC2 but not with HDCA3. After EHMT2 knockdown, multiple genes were regulated, including CD5 and CCND1, mostly enriched in the Tec kinase signaling pathway. In addition, several genes (e.g., MARCH1, CCDC50, HIP1, and WNT3) were aberrantly methylated in EHMT2 + MCLs.

Conclusions

For the first time, we determined the significance of EHMT2 in MCL and identified potential EHMT2-regulated genes.

Keywords

DNA methylationgene expressionmantle cell lymphomaepigenetic biomarkerEHMT2

Electronic Supplementary Material

Download File(s)
cbm-19-6-836_ESM.pdf (161.9 KB)

References

1

Leshchenko VV, Kuo PY, Shaknovich R, Yang DT, Gellen T, Petrich A, et al. Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma. Blood. 2010; 116: 1025-34.
Crossref Google Scholar
2

Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 1994; 13: 2124-30.
Crossref Google Scholar
3

Wang YF, Zhang J, Su Y, Shen YY, Jiang DX, Hou YY, et al. G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin. Nat Commun. 2017; 8: 274.
Crossref Google Scholar
4

Wei L, Chiu DK, Tsang FH, Law CT, Cheng CL, Au SL, et al. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J Hepatol. 2017; 67: 758-69.
Crossref Google Scholar
5

Kim KB, Son HJ, Choi S, Hahm JY, Jung H, Baek HJ, et al. H3K9 methyltransferase G9a negatively regulates UHRF1 transcription during leukemia cell differentiation. Nucleic Acids Res. 2015; 43: 3509-23.
Crossref Google Scholar
6

Goyama S, Nitta E, Yoshino T, Kako S, Watanabe-Okochi N, Shimabe M, et al. EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization. Leukemia. 2010; 24: 81-8.
Crossref Google Scholar
7

Lund T, Carter C, Campbell RD. Pulsed field gel electrophoretic analysis of the rat major histocompatibility complex class Ⅲ region shows extensive inter-species conservation. Mamm Genome. 1994; 5: 282-7.
Crossref Google Scholar
8

Matsuzaka Y, Makino S, Nakajima K, Tomizawa M, Oka A, Bahram S, et al. New polymorphic microsatellite markers in the human MHC class Ⅲ region. Tissue Antigens. 2001; 57: 397-404.
Crossref Google Scholar
9

Mauger O, Klinck R, Chabot B, Muchardt C, Allemand E, Batsche E. Alternative splicing regulates the expression of G9a and SUV39H2 methyltransferases, and dramatically changes SUV39H2 functions. Nucleic Acids Res. 2015; 43: 1869-82.
Crossref Google Scholar
10

Dong KB, Maksakova IA, Mohn F, Leung D, Appanah R, Lee S, et al. DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity. EMBO J. 2008; 27: 2691-701.
Crossref Google Scholar
11

Zhong X, Chen X, Guan X, Zhang H, Ma Y, Zhang S, et al. Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis. Histopathology. 2015; 66: 192-200.
Crossref Google Scholar
12

Barcena-Varela M, Caruso S, Llerena S, Alvarez-Sola G, Uriarte I, Latasa MU, et al. Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma. Hepatology. 2019; 69: 587-603.
Crossref Google Scholar
13

Chen MW, Hua KT, Kao HJ, Chi CC, Wei LH, Johansson G, et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res. 2010; 70: 7830-40.
Crossref Google Scholar
14

Casciello F, Al-Ejeh F, Kelly G, Brennan DJ, Ngiow SF, Young A, et al. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis. Proc Natl Acad Sci U S A. 2017; 114: 7077-82.
Crossref Google Scholar
15

Hua KT, Wang MY, Chen MW, Wei LH, Chen CK, Ko CH, et al. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis. Mol Cancer. 2014; 13: 189.
Crossref Google Scholar
16

Casciello F, Windloch K, Gannon F, Lee JS. Functional role of G9a histone methyltransferase in cancer. Front Immunol. 2015; 6: 487.
Crossref Google Scholar
17

Li KC, Hua KT, Lin YS, Su CY, Ko JY, Hsiao M, et al. Inhibition of G9a induces DUSP4-dependent autophagic cell death in head and neck squamous cell carcinoma. Mol Cancer. 2014; 13: 172.
Crossref Google Scholar
18

Agarwal P, Jackson SP. G9a inhibition potentiates the anti-tumour activity of DNA double-strand break inducing agents by impairing DNA repair independent of p53 status. Cancer Lett. 2016; 380: 467-75.
Crossref Google Scholar
19

Lehnertz B, Pabst C, Su L, Miller M, Liu F, Yi L, et al. The methyltransferase G9a regulates HoxA9-dependent transcription in AML. Genes Dev. 2014; 28: 317-27.
Crossref Google Scholar
20

Kim JK, Esteve PO, Jacobsen SE, Pradhan S. UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells. Nucleic Acids Res. 2009; 37: 493-505.
Crossref Google Scholar
21

Ferry L, Fournier A, Tsusaka T, Adelmant G, Shimazu T, Matano S, et al. Methylation of DNA ligase 1 by G9a/GLP recruits UHRF1 to replicating DNA and regulates DNA methylation. Mol Cell. 2017; 67: 550-65.e5.
Crossref Google Scholar
22

Tamaru H, Selker EU. A histone H3 methyltransferase controls DNA methylation in Neurospora crassa. Nature. 2001; 414: 277-83.
Crossref Google Scholar
23

Zhang C, Du X, Tang K, Yang Z, Pan L, Zhu P, et al. Arabidopsis AGDP1 links H3K9me2 to DNA methylation in heterochromatin. Nat Commun. 2018; 9: 4547.
Crossref Google Scholar
24

Mishra S, Van Rechem C, Pal S, Clarke TL, Chakraborty D, Mahan SD, et al. Cross-talk between lysine-modifying enzymes controls site-specific DNA amplifications. Cell. 2018; 174: 803-17.e16.
Crossref Google Scholar
25

Cui H, Hu Y, Guo D, Zhang A, Gu Y, Zhang S, et al. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in emt-related metastasis of gastric cancer. Oncogene. 2018; 37: 4358-71.
Crossref Google Scholar
26

Kim G, Kim JY, Lim SC, Lee KY, Kim O, Choi HS. SUV39H1/DNMT3A-dependent methylation of the RB1 promoter stimulates PIN1 expression and melanoma development. FASEB J. 2018; 32: 5647-60.
Crossref Google Scholar
27

Talebizadeh Z, Shah A, DiTacchio L. The potential role of a retrotransposed gene and a long noncoding RNA in regulating an X-linked chromatin gene (KDM5C): Novel epigenetic mechanism in autism. Autism Res. 2019; 12: 1007-21.
Crossref Google Scholar
28

Liu C, Yu Y, Liu F, Wei X, Wrobel JA, Gunawardena HP, et al. A chromatin activity-based chemoproteomic approach reveals a transcriptional repressome for gene-specific silencing. Nat Commun. 2014; 5: 5733.
Crossref Google Scholar
29

Mozzetta C, Pontis J, Fritsch L, Robin P, Portoso M, Proux C, et al. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing. Mol Cell. 2014; 53: 277-89.
Crossref Google Scholar
30

Scheer S, Zaph C. The lysine methyltransferase G9a in immune cell differentiation and function. Front Immunol. 2017; 8: 429.
Crossref Google Scholar
31

Gyory I, Wu J, Fejer G, Seto E, Wright KL. PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat Immunol. 2004; 5: 299-308.
Crossref Google Scholar
32

Thomas LR, Miyashita H, Cobb RM, Pierce S, Tachibana M, Hobeika E, et al. Functional analysis of histone methyltransferase G9a in B and T lymphocytes. J Immunol. 2008; 181: 485-93.
Crossref Google Scholar
33

Zhu L, Yan F, Wang Z, Dong H, Bian C, Wang T, et al. Genome-wide DNA methylation profiling of primary colorectal laterally spreading tumors identifies disease-specific epimutations on common pathways. Int J Cancer. 2018; 143: 2488-98.
Crossref Google Scholar
34

Fang F, Wang X, Song T. Five-CpG-based prognostic signature for predicting survival in hepatocellular carcinoma patients. Cancer Biol Med. 2018; 15: 425-33.
Crossref Google Scholar
35

Kanduri M, Sander B, Ntoufa S, Papakonstantinou N, Sutton LA, Stamatopoulos K, et al. A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma. Epigenetics. 2013; 8: 1280-8.
Crossref Google Scholar
36

Niu X, Liu F, Zhou Y, Zhou Z, Zhou D, Wang T, et al. Genome-wide DNA methylation analysis reveals GABBR2 as a novel epigenetic target for EGFR 19 deletion lung adenocarcinoma with induction erlotinib treatment. Clin Cancer Res. 2017; 23: 5003-14.
Crossref Google Scholar
37

Ma R, Feng N, Yu X, Lin H, Zhang X, Shi O, et al. Promoter methylation of Wnt/beta-Catenin signal inhibitor TMEM88 is associated with unfavorable prognosis of non-small cell lung cancer. Cancer Biol Med. 2017; 14: 377-86.
Crossref Google Scholar
38

Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, et al. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin’s lymphomas, Hodgkin’s disease, or lymphomatoid papulosis. Blood. 1996; 88: 1771-9.
Crossref Google Scholar
39

Feldman AL, Dogan A, Smith DI, Law ME, Ansell SM, Johnson SH, et al. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing. Blood. 2011; 117: 915-9.
Crossref Google Scholar
40

Maurus K, Appenzeller S, Roth S, Kuper J, Rost S, Meierjohann S, et al. Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma. J Invest Dermatol. 2018; 138: 1573-81.
Crossref Google Scholar
41

Gascoyne DM, Lyne L, Spearman H, Buffa FM, Soilleux EJ, Banham AH. Vitamin D receptor expression in plasmablastic lymphoma and myeloma cells confers susceptibility to Vitamin D. Endocrinology. 2017; 158: 503-15.
Crossref Google Scholar
42

Pike BL, Greiner TC, Wang X, Weisenburger DD, Hsu YH, Renaud G, et al. DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status. Leukemia. 2008; 22: 1035-43.
Crossref Google Scholar
43

Nwabo Kamdje AH, Mosna F, Bifari F, Lisi V, Bassi G, Malpeli G, et al. Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells. Blood. 2011; 118: 380-9.
Crossref Google Scholar
44

Blombery P, Thompson ER, Jones K, Arnau GM, Lade S, Markham JF, et al. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica. 2016; 101: e387-90.
Crossref Google Scholar
45

Sotillo E, Barrett DM, Black KL, Bagashev A, Oldridge D, Wu G, et al. Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov. 2015; 5: 1282-95.
Crossref Google Scholar
46

Fukuda M, Sakaue-Sawano A, Shimura C, Tachibana M, Miyawaki A, Shinkai Y. G9a-dependent histone methylation can be induced in G1 phase of cell cycle. Sci Rep. 2019; 9: 956.
Crossref Google Scholar
47

Li Z, Jiao X, Di Sante G, Ertel A, Casimiro MC, Wang M, et al. Cyclin D1 integrates G9a-mediated histone methylation. Oncogene. 2019; 38: 4232-49.
Crossref Google Scholar
48

Musri MM, Carmona MC, Hanzu FA, Kaliman P, Gomis R, Parrizas M. Histone demethylase LSD1 regulates adipogenesis. J Biol Chem. 2010; 285: 30034-41.
Crossref Google Scholar
49

Cordero-Herrera I, Chen X, Ramos S, Devaraj S. (-)-Epicatechin attenuates high-glucose-induced inflammation by epigenetic modulation in human monocytes. Eur J Nutr. 2017; 56: 1369-73.
Crossref Google Scholar
50

Esteve PO, Chin HG, Smallwood A, Feehery GR, Gangisetty O, Karpf AR, et al. Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev. 2006; 20: 3089-103.
Crossref Google Scholar
Cancer Biology & Medicine
Volume 19 Issue 6,
June 2022
Pages 836-849
DOI: 10.20892/j.issn.2095-3941.2020.0371
Cite this article:
Wang J, Xu H, Ge S, et al. EHMT2 (G9a) activation in mantle cell lymphoma and its associated DNA methylation and gene expression. Cancer Biology & Medicine, 2022, 19(6): 836-849. https://doi.org/10.20892/j.issn.2095-3941.2020.0371

104

Views

2

Downloads

3

Crossref

5

Web of Science

5

Scopus

Altmetrics
Received: 01 August 2020
Accepted: 01 December 2020
Published: 12 October 2021
©2022 Cancer Biology & Medicine.

Creative Commons Attribution-NonCommercial 4.0 International License
Return